An open-label, prospective phase I/II study evaluating the immunogenicity and safety of a ras peptide vaccine plus GM-CSF in patients with non-small cell lung cancer

✍ Scribed by Meyer, Ralf G.; Korn, Stephanie; Micke, Patrick; Becker, Kai; Huber, Christoph; Wölfel, Thomas; Buhl, Roland

• Book ID: 119319668
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 216 KB
• Volume: 58
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/j.lungcan.2007.05.003